share_log

Watching Palisade Bio; Ladenburg Gives Stock Buy Rating And $25 Price Target Says Spoke to Pali Management, Growing More Confident In The Regulatory Path LB1148 May Take Forward As The Topline Ph2 Data On The Prevention Of Post-surgical Abdominal Adhesion

Benzinga Real-time News ·  Jan 31, 2023 13:38
Watching Palisade Bio; Ladenburg Gives Stock Buy Rating And $25 Price Target Says Spoke to Pali Management, Growing More Confident In The Regulatory Path LB1148 May Take Forward As The Topline Ph2 Data On The Prevention Of Post-surgical Abdominal Adhesion
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment